A group of scientists from Canada found that the non-coding part of the human genome, the so-called "junk" DNA, can be used for immunotherapy of cancer. They published their methodology in the journal Science Translational Medicine.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.